Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2021 February;112(1) > Minerva Medica 2021 February;112(1):114-7

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

EDITORIAL   Freefree

Minerva Medica 2021 February;112(1):114-7

DOI: 10.23736/S0026-4806.20.06727-0

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Severe asthma at COVID-19 time: what is new on biologic therapies

Filippo PATRUCCO 1, 2 , Elisa VILLA 3, Valentina FOCI 4, Alida BENFANTE 5, Michela BELLOCCHIA 6, Paolo SOLIDORO 6, 7

1 Division of Respiratory Diseases, Department of Medicine, Maggiore della Carità University Hospital, Novara, Italy; 2 Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy; 3 Unit of Pneumology, A.S.L. Genova3, Villa Scassi Hospital, Genoa, Italy; 4 Unit U of Pneumology, Department of Medicine, A.S.L. Vercelli, Vercelli, Italy; 5 ProMISE Department, University of Palermo, Palermo, Italy; 6 Unit U of Pneumology, Department of Cardiovascular and Thoracic Medicine, Città della Salute e della Scienza, University of Turin, Turin, Italy; 7 Department of Medical Sciences, University of Turin, Turin, Italy



inizio pagina